MILLER MARVIN J has a total of 22 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are REVOLUTION MEDICINES INC, VIROPHARMA INC and RODIN THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 2 | |
#5 | Chile | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Peru | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Miller Marvin J | 22 |
#2 | Moraski Garrett | 13 |
#3 | Moraski Garrett C | 4 |
#4 | Ji Cheng | 3 |
#5 | Stefely Jonathan | 3 |
#6 | Ghosh Manuka | 2 |
#7 | Lin Yun-Ming | 2 |
#8 | Miller Patricia A | 2 |
#9 | Yang Yang | 1 |
#10 | Branagan Sean | 1 |
Publication | Filing date | Title |
---|---|---|
CN108348510A | For mycobacterial infections useful heterocyclic compound and composition containing benzylamine | |
WO2016027262A1 | Antibacterial sideromycins | |
US2016368878A1 | Reduction-triggered antibacterial sideromycins | |
WO2009111502A2 | Anti-cancer compounds, synthesis thereof, and methods of using same |